Background: Large granular lymphocyte (LGL) leukemia is an uncommon cancer characterized 24 by a sustained clonal proliferation of LGL cells. Antibodies reactive to retroviruses have been 25 documented in the serum of patients with LGL leukemia. Culture or molecular approaches have 26 to date not been successful in identifying a retrovirus. 27 Methods: Because a retrovirus must integrate into the genome of an infected cell, we focused 28 our efforts on detecting a novel retrovirus integration site in the clonally expanded LGL cells. 29
4
Serum antibodies from LGL leukemia patients recognize an antigen with homology to a protein 69 encoded by human T-lymphotropic virus (HTLV) [7, 8] , providing a potential link of this disease 70 with retroviruses. The oncogenic potential of retroviruses is well established in mammals and 71 birds, which can develop cancers of hematopoietic cells [9] following retroviral infection. 72
Although there are numerous mechanisms for retrovirus-induced oncogenesis, dysregulation of 73 key cell cycle control genes during retroviral integration and transduction of cellular oncogenes 74 are particularly well documented [9] [10] [11] . While many cancers in animals have a retrovirus 75 etiology, HTLVs are the only retrovirus group definitively linked to cancer in humans. In this 76 case, a virus-encoded accessory protein is necessary for cell transformation [12, 13] . Despite a 77 high prevalence of HTLV-1 antigen responders among LGL leukemia patients, intensive 78 molecular and culture-based approaches have failed to detect HTLV, or any known retrovirus, in 79
LGL leukemia patients. However, such methods could fail to identify a defective retrovirus, 80 which is relevant because many animal oncogenic retroviruses are replication-defective and can 81 have unusual genome sequence [14, 15] . Because LGL leukemia involves a clonal expansion of 82
LGL cells, we reasoned that if a retrovirus initiated the malignancy, we should be able to detect 83 the integrated virus in LGL genomes even if it couldn't be recovered in culture. The goal of this 84 study was to interrogate LGL genomes of LGL leukemia patients for the presence of a novel 85 retrovirus to determine if the clonal expansion of LGL cells is preceded by the integration of a 86 novel or known retrovirus. 87 Long insert mate pair libraries of 11 LGL patients (S1-S11) were prepared and sequenced at the 99 Duke Center for Genomic and Computational Biology using the Illumina Nextera MP kit. 100
Sequencing was performed on a HiSeq and read length was 125bp. Paired-end sequencing of 48 101
LGL patients was conducted by Illumina. Patients S9, S10, and S11 were paired-end sequenced 102 at Penn State by Dr. Stephan Schuster. 103
104

PCR assessment of four non-reference polymorphic HERV-K. 105
A 25 µl PCR reaction was performed using human adult normal peripheral blood leukocyte 106 genomic DNA purchased from Biochain (Cat. #D8234148-1, Lot #B511221) and the following 107 primer pairs: 108
Chr1_5HK For (5'CATAGCAAATCCCAGTGTAGACATC3') and 109
Chr1_5HK Rev (5'CTGGGAGCATTTCTGGACATC3'); 110
Chr1_PREINT For (5'CACCGCACCTGGCAAGTTTACA3') and 111
Chr1_PREINT Rev (5'ATTTGGGGTCCTCATGAAGCAGAA3'); 112
Chr19_3HK5 For (5'TACCCCAAGACCAAAAATAATAAG3') and 113 6 Chr19_3HK6 Rev (5'CTGATAGTGGCAAGATGGATGTA3'); 114 C19PRE3 For (5'GAACAGGAGCATGCTCATAGTGTGT3') and 115 C19PRE4 Rev (5'GGTCTCGAACTCCTAACCTCCTG3'); 116
Chr12PREINT For (5'TACTGGGAATAAGATGATGATGGT3') and 117
Chr12PREINT Rev (5'TTTGTTAAGTGCTCGGAAGGT3'); 118 Chr10HK1 For (5'ACGCGTGGGTATATCGGTTTATTTCT3') and 119
Chr10HK2 Rev (5'GGCTGGTTCTTTATTATTTATGGCTGGT3'); 120 Chr12HK5_1 For (5'GCAGTTCCACCTTCCCGACAGC3') and 121
Chr12HK5_2 Rev (5'ACACAGGACCAAAAGAACGAGTAATC3'). 122
123
Each 25 µl reaction contained 12.5 µl 2x MyTaq HS Red Mix, 2 µl 5µM forward primer, 2 µl 124 5µM reverse primer, 3.5 µl nuclease-free water and 20 ng of the pre-dispensed genomic DNA. 125
The reactions were cycled using a Bio-Rad C1000 Touch 96-deep well cycler. The cycled 126 reaction and HyperLadder 1 kb DNA ladder were electrophoresed on a 1% agarose gel with 1x 127 TAE for 60 minutes at 80V. The gel was visualized using 10,000x Sybr Safe DNA Gel Stain and 128 images were captured using the Bio-Rad ChemiDoc and Image Lab software. 129 130 Insertion Call Pipeline. 131 7 mapped, and partially mapped reads ( Figure 1 ). Parameters of the caller were tuned using a 137 simulation to detect 5-12 kbp insertions of at least 55% prevalence in a sample. The tracks were 138 integrated to identify candidate insertion events. The sequence content of each candidate 139 insertion was investigated by gathering the read pairs that map near the insertion, assembling 140 them and querying the resultant contigs against the NCBI nt database using BLAST. BLAST 141 results were searched for infectious or endogenous retrovirus hits based on taxonomy 142 identification ( Figure S3 ). Endogenous retrovirus hits that had host flanking regions were 143 confirmed to be from the candidate insertion site by mapping to the reference genome. 144
Polymorphic HERV-K insertions were confirmed with an approach (Additional File 145 S1_Supplementary Methods Methods and [17]) independent of the insertion call pipeline. 146
147
Results 148
Detecting retroviral integrations in LGL leukemia patient genomes. 149
There is compelling evidence for retroviral involvement in LGL leukemia [18, 19] . Because a 150 retrovirus must integrate into the host genome as part of its life cycle, we focused our 151 methodology to detect retroviral insertions in the genomes of LGL cells from LGL leukemia 152 patients because they are a clonal cell population. Identifying a unique retrovirus integration site 153 in a patient's genome is complicated because reads derived from the retrovirus will not map to a 154 reference genome. Thus, we developed a two-step pipeline (Additional File S1_Supplementary 155 Methods) that first detects insertion events in the patient genome and then determines if the 156 insertion is of retroviral origin. Both steps of our method exploit specific mapping properties of 157 long insert (8 kbp) mate pair data to identify retrovirus insertions ( Figure 1 ). 158 159 8 Briefly, a read within approximately 5-12 kbp of a newly inserted retrovirus will map to the 160 reference genome (anchoring mate, dark blue in Figure 1 ) while its mate will be derived from the 161 retrovirus and will not map (unmapped mate, orange in Figure 1 ) or could map to a location such 162 as an endogenous retrovirus element elsewhere in the genome if there is sufficient homology 163 (discordant mate); either case results in a broken pair of read mates with one mapping to the 164 reference genome and one that does not map within the appropriate distance. Depending on the 165 length of the retrovirus, which typically is 6-10 kbp, some mate pairs may span the entire 166 inserted virus and hence both mate pairs will originate from the host (light blue in Figure 1 ). 167
However, because the retrovirus is not present in the reference genome, these mate pairs will 168 map at a distance shorter than the expected insert distribution of 5-12 kbp. The insert length and 169 depth of mapped reads are key signals in our retrovirus insertion pipeline. 170
171
We used a simple simulation to explore how features of long insert mate pair mapping could be 172 integrated to call an insertion compatible with a retroviral integration, to set parameters, and to 173 determine how the pipeline performed for retroviruses of different lengths and at different 174 prevalence in the sample. (Additional File S1_Supplementary Methods, Figure S1 and Table S1 ). 175
The results of the simulation demonstrated that our ability to detect a retrovirus insertion 176 depended both on the length of the retrovirus and the prevalence in the sample. If more than 80% 177 of the cells carry a retroviral integration of any length, they are detectable in the simulation. 178
Retroviruses longer than 8 kbp cannot reliably be detected if their prevalence in the sample is 179 less than 60%. This is primarily because we lose the signal from the short insert length track with 180 longer retrovirus insertions because longer viruses will cause the insert length to exceed that 181
represented by our mate pair library and only one of the mates will map. We account for longer 182 9 retroviruses in an alternative approach (discussed below, see Additional File S1_Supplementary 183 Methods). The proportion of LGL in the peripheral blood of LGL leukemia patients is typically 184 65-80%, which is within the range that our simulation indicates we can reliably detect 185 retroviruses across the size spectrum. Thus, we applied the pipeline to our WGS data, using the 186 parameters established by the simulation. 187
188
We first applied this pipeline to the long insert mate pair WGS data of LGL leukemia patient S10, 189 who had a PBMC count consisting of 80% clonal LGL cells. These data are displayed as tracks 190 for a genome browser and each candidate insertion site can be accessed from a catalogue of all 191 insertion calls. The first step of the insertion call pipeline is intentionally permissive to false 192 positives because we implement a second step that utilizes the discordant mate pair data to detect 193 retroviral sequences at each called insertion. Discordant mates identified at each called insertion 194 site (represented in Track 4, Figure S1 and S2) are assembled and queried against the NCBI 195 database using BLAST+ [20, 21] (Additional File S1_Supplementary Methods). We anticipated 196 that the majority of insertions would be known genome structural variants in the human 197 population that are not in the hg19 reference genome but are represented in the NCBI nt database. 198
If this is the case, multiple contigs generated from assembling the discordant mate pairs at the 199 called insertion will have a best match (lowest e-value) to the same database entry, and have a 200 taxonomy ID of 'human'. A taxonomy ID and name search of the BLAST output using 201 'retrovirus' was applied to all contigs that were not identified as human. There were no 202 detectable retrovirus matches in S10 sequence data using these criteria. 203 204 10
We further queried candidate insertions for key word 'endogenous retrovirus' (ERV), because 205 there are polymorphic ERVs in the human population that are absent from hg19, many of which 206 are represented in BAC clones; these would also appear as an insertion in our pipeline. Candidate 207 human endogenous retrovirus (HERV) insertions were confirmed by two criteria: the contigs 208 derived from unmapped mates mapped to a HERV in the NCBI nt database and the host regions 209 flanking the HERV in the NCBI nt entry could be aligned to the reference human genome (hg19) 210 in the interval defined by the anchoring mates near the called insertion. We detected four 211 polymorphic HERV-K elements absent from hg19 in patient S10; these include two sites 212 Our data indicate that there is no clonal integration of a novel retrovirus, either exogenous or 222 endogenous, in the LGL leukemia cells. However, this does not rule out that a retrovirus 223 contributes to this disease. Our samples come from PBMC and spleen, both of which contain 224 normal cells that are frequently targets for retrovirus infection. The insertion call tool was 225 designed to detect a retrovirus integration of 9 kbp or less in the clonally expanded LGL cells; a 226 longer retrovirus or a retrovirus that integrated into non-leukemic cells would be below the level 227 11 of sensitivity of our method. We took two additional approaches to search for a low frequency 228 integration event in the sample. All unmapped reads that passed a quality filter were assigned 229 taxonomy identification provided from SNAP [23] mapping (Additional File S1_Supplementary 230 Methods Methods). All reads with a 'virus' taxonomy classification were further scrutinized by 231 BLAST search to determine if the best match was to a retrovirus. None were identified. We also 232 mapped all long insert mate pair WGS reads to a full length HERV-K (GenBank accession 233 number: JN675087) and assigned their mates to a position in hg19 to search for candidate de 234 novo insertions of a HERV-K. Again, none were detected. Thus, we can confirm that there is not 235 a clonal integration of an unknown exogenous or endogenous retrovirus in the LGL leukemia 236 cells themselves and that we were not able to detect evidence of a novel retrovirus integration 237 site in the genomes of non-leukemic cells that were represented in our WGS data. 238 239 This investigation was motivated by data showing that LGL patients have sero-recognition of 240 HTLV proteins, although they are not infected with this virus [8, 18, 24] . Our detailed 241 investigation of LGL genomes from 11 leukemia patients (S1-S11) failed to detect a novel 242 retrovirus integration site in circulating LGL that could elicit this antibody response, but we did 243 identify several HERV-Ks that are polymorphic in humans and absent from the human reference 244 genome. Endogenous retroviruses have been implicated in several cancers including leukemia 245 [25, 26] and immune response to HERV proteins has been reported in both cancer and 246 autoimmune diseases [27] [28] [29] . Of the reported polymorphic HERV-K, 16 are close to full length 247 [17, 22] . However, the distribution of all polymorphic HERV-K in cancer patients compared to 248 the population at large is at present unknown. We thus investigated whether the prevalence of 249 polymorphic HERV-K -individually or co-occurring -or the total number of polymorphic 250 12 HERV-K in a person's genome differed between LGL leukemia patients and normal populations 251 represented in the KGP data [17, 30] . 252
253
Our detection method to identify retroviral insertions used in this paper depended on long insert 254 mate pair sequencing, which is not typically available for the large genomic databases needed to 255 determine the prevalence of polymorphic HERV-K in global populations. We recently reported 256 on a method that utilizes unique k-mers present in each published HERV-K provirus to estimate 257 the proviral prevalence of polymorphic HERV-K proviruses in any individual from paired-end 258 sequence data [17] . The output of the pipeline is the ratio (n/T) of k-mers from a query set (n) to 259 the total number of unique k-mers (T) for each HERV-K proviral insertion. We applied this 260 approach to a set of 51 LGL leukemia patients, 11 of which (S1-S11) also had long-insert mate 261 pair sequence data available. LGL patients in this study (51 total), ELGL: T-LGL patients with European ancestry (T-LGL-287 EUR, 40 total). 288
289
We verified the estimates of HERV-K presence in LGL patients from our pipeline in two ways. 290
The four polymorphic HERV-K proviruses that are absent in hg19 were identified in our 291 14 insertion call pipeline and we confirmed the presence of a provirus using discordant mate pair 292 sequences for 11 patients (S1-S11). We also used the mate pair data to confirm the status of the 293 remaining 16 polymorphic HERV-K that are represented in hg19; the results for HERV-K status 294 based on our data mining tool and mate pairs are 100% concordant. In addition, we amplified 295 both the preintegration site and a portion of HERV-K including the host flanking sequence for 296 the four polymorphic HERV-K that were identified in the insertion call pipeline in 48 of the LGL 297 patients (LGL) and 48 individuals with no diagnosed diseases (European, African-American and 298 Hispanic origin; hereafter referred to as "normal"). The results from the PCR assay for 299 chr19:22414379-22414380 (normal 56%, LGL patient 50%) and chr12:55727215-55728183 300 (normal 82%, LGL patients 71%) agree with our computational analysis (Table S2 ). The 301 chr10:27182399-27183380 HERV-K was amplified in all LGL patients and normal individuals, 302 which is consistent with the high prevalence (99%) found in our data mining method. 303 chr1:73594980-73595948 was also present in all patients and normals by PCR but we have no 304 data on this virus from our KGP analysis because the build of the reference genome (GRCh37) 305 used to map KGP reads included hs37d5, a concatenated decoy sequence which contains this 306 virus, while our approach used coordinates of hg19. Hence the reads needed to identify 307 chr1:73594980-73595948 were not extracted in the data mining step [17] . 308
309
We performed a linear discriminant analysis (LDA) to determine if the signal in the HERV-K 310 prevalence data was sufficient to distinguish the T-LGL-EUR patient population from EUR. For 311 this analysis we used only the 28 individuals from the KGP data sets with high coverage (~30x 312 sequencing depth) data, after confirming that none were outliers in their population clusters of all 313 KGP data (~5x sequencing depth) [17] . Based on the data reduced to the states 'absence, solo 314 15 LTR, provirus' of each HERV-K insertion, T-LGL-EUR patients separate from EAS and AFR 315 but were admixed with EUR, AMR and SAS (Figure 2A ). We previously showed that using the 316 n/T ratio provided better resolution of the KGP populations [17], presumably because it captures 317 allelic differences in both fixed and polymorphic HERV-K. Based on n/T, T-LGL-EUR patients 318 are well separated from all KGP populations ( Figure 2B) . These data indicate that both the 319 polymorphic HERV-K and specific allelic forms of each HERV-K provirus define the T-LGL 320 patient population. 321
322
An n/T ratio of 1 indicates that the reference allele (typically from hg19) is present. We 323 suggested in [17] that n/T less than 1 indicates that an individual has an allele of the HERV-K at 324 a locus that is not represented in the database. Using the unmapped mates from those reads 325 flanking a HERV-K locus, we reconstructed the sequence of a polymorphic HERV-K proviruses 326 at chr3:112743479-112752282, which is presented here because there is considerable variation in 327 n/T in both LGL patients ( Figure S4A ) and KGP [17] . For individuals with n/T=1, all reads map 328 perfectly to the unique k-mers representing the reference alleles. However, LGL patients with 329 n/T<1 have five substitutions in this HERV-K, one common to the 11 patients (S1-S11) with 330 long insert mate pair data and four sites that were variably present among these individuals 331 ( Figure S4B ), which accounts for the differences in n/T. These data demonstrate that n/T can 332 reflect allelic differences at a HERV-K locus and indicate why the n/T ratio contains more 333 information than the presence, absence data to distinguish populations. 334 335 Genomic structural variations are often noted in cancer cells of diverse origins [33, 34] . Because 336 HERV-Ks are polymorphic in the genome some individuals have a higher burden of these 337 16 repetitive elements than others. We considered that an increased number of polymorphic HERV-338 K proviruses could contribute to the sustained clonal proliferation that characterizes LGL 339 leukemia by increasing chromosomal re-arrangements [35] [36] [37] . In the KGP datasets, no 340 individual had fewer than 7 or more than 18 of the 20 polymorphic HERV-K proviruses 341 evaluated and ~50% of all individuals from each of the KGP populations have 12 or 13 342 polymorphic provirus insertions except for EAS, where 52% of the sampled individuals have 10 343 or 11 polymorphic integration sites [17] . T-LGL-EUR patients carry between 9 and 16 HERV-K 344 proviruses ( Figure 3 ) at proportions that are significantly different than those found in EUR 345 individuals (Kolmogorov-Smirnov test, p=0.0087; Table S2 ). Notably, 35% of T-LGL-EUR 346 individuals carry 14 proviruses while the carriage rate for this number of HERV-K proviruses 347 among the five KGP populations is 2-22%. Hence, the LGL leukemia patients sampled in this 348 analysis carry a higher burden of polymorphic HERV-K than is seen in the general population. 349
350
Because LGL leukemia patients, and particularly T-LGL leukemia patients, have more 351 proviruses in their genomes, we reasoned that co-occurrence of the polymorphic HERV-Ks 352 could also vary from EUR or other global populations. This is the case for several HERV-K 353 combinations that include chr12: 58721242-58730698, which is present in 98% of T-LGL 354 leukemia patients ( Figure 4A) . Interestingly, there are combinations of HERV-K, with or without 355 chr12: 58721242-58730698, that are higher in LGL patients than in EUR but similar to AFR and 356 EAS populations, which have the lowest prevalence of chr12: 58721242-58730698 of the KGP 357 populations ( Figure 4B) . These data suggest that the prevalence of co-occurring HERV-K should 358 be considered when investigating a role of HERV-K in the pathogenesis of a specific disease. Our previous analysis of the KGP data also suggested that there were alleles of HERV-K 386 proviruses not found in the NCBI databases; these are represented by an n/T ratio of less than 1 387
[17]. We reconstructed the provirus sequences at HERV-K loci using patient long insert mate 388 pair WGS data to confirm that our analysis tool does report allelic differences in HERV-K that 389 are not found in any of the reference HERV-K that localize to that site. We call these unknown 390 alleles because we require 100% match of query k-mers from patient WGS to the set of k-mers, 391 T, which represent k-mers unique to all alleles present in public databases of a HERV-K at a 392 specific locus. If a k-mer derived from a patient contains a sequence polymorphism at any 393 position of the unique reference k-mer set T, it will be excluded in the k-mer count, effectively 394 decreasing n/T to less than 1. It is notable that there is substantial variation in n/T for both fixed 395 and polymorphic HERV-K and these differences, not presence or absence of a HERV-K, 396 distinguish the KGP super-populations [17] . Although population-specific alleles have been 397 reported [40] , our data highlight more extensive sequence variation among HERV-Ks than has 398 previously been recognized and suggest that both sequence and occupancy of a site should be 399 considered when assessing the potential role of HERV-K in disease. This is an important 400 consideration because using a consensus sequence or specific reference sequence might not 401 reflect the HERV-K in a patient population. 402
403
Our study was motivated by serological evidence of a retrovirus in LGL patients that was not a 404 known human retrovirus. The data we present do not rule out the contribution of an infectious 405 19 retrovirus to LGL leukemia pathogenesis. The insertion call pipeline developed herein would 406 only identify a clonal integration of a new retrovirus in the LGL leukemia cells, which comprise 407 greater than 60% of the peripheral mononuclear cell population, or a new somatic or germline 408 insertion in the case of a polymorphic HERV-K. Our conclusion that the cells sampled from 409 patients do not harbor an integrated retrovirus is additionally supported by the negative results of 410 the SNAP analysis, which interrogated all reads for evidence of a retrovirus. Thus, we consider File S1. Supplementary Methods and Data. Figure S1 -S4 are embedded. 442 Table S1 . Results of 10 simulated runs to determine how the proportion of infected cells and the 443 length of the retrovirus affects detection by the insertion pipeline. 444 Table S2 . The output of the pipeline to investigate HERV-K proviruses and prevalence of 445 polymorphic HERV-K proviruses in 51 LGL leukemia patients. The complete WGS datasets analyzed during the current study are not publicly available because 458 a full analysis of the genome sequence for other purposes is ongoing. However, the bam files 459 used for analysis of HERV-K provirus occupancy will be made publically available is the 460 manuscript is accepted for publication. The long insert mate pair data from 11 patients are 461 available from the corresponding author on reasonable request. 462 463 
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